Abstract
AbstractAntipsychotics for Youth at Risk for Psychosis Not Supported as First OptionRelative Age in Class Affects ADHD Stimulant TreatmentSurvey Analysis Does Not Point to OvermedicationHyperprolactinemia Found in Risperidone‐Treated YouthFree the Future: Investment in MH Services Crucial Post‐NewtownPediatric Social Anxiety Disorder: Predictors of Response to Pharmacological TreatmentZiprasidone vs. Olanzapine for 1st‐Episode SchizophreniaUtilization and Cost of Antipsychotics in Stimulant‐Treated YouthAcute Myocardial Infarction in Teen Taking Adderall with AlcoholManaging Side Effects of ADHD MedicationsNew Requirements for Zolpidem Products
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Brown University Child & Adolescent Psychopharmacology Update
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
